Het verbeteren van de klinische implementatie van nanogebaseerde kankertherapieën

Despite significant advances in cancer therapy over the past decades, cancer remains the number one cause of death worldwide. In the last years there has been increasing interest in the development of new treatment modalities with reduced side effects for difficult-to-cure cancers. A prominent example is Photothermal Therapy (PTT), designed to selectively kill cancerous tissue in the body through localized, light-induced thermal stress. The development of nanomaterials marks a significant step forward in photothermal therapy of cancers. Nanomaterials smaller than 200 nm accumulate in the tumour tissue and exhibit strong absorption in the near-infrared range, making them effective photothermal transducers with cancer targeting capabilities. Nanomaterial-mediated PTT has reached clinical trials but knowledge concerning the efficiency, mechanism and toxicity of this therapy remains limited. This project aims to unravel the mechanisms involved in nanomaterial-mediated PTT, using microscopy to monitor intracellular temperature and cell death pathways simultaneously. To mimic the physiological features present in solid tumors most accurately, multicellular tumor spheroids will be used. The fabrication and characterisation of novel nanomaterials will also be a major part of this project, targeting nanosensors for mapping intracellular temperature, and gold-based stimuli-responsive nanocrystals with enhanced solid tumor penetration and efficient photothermal transduction for long-wavelength light. The information obtained thereby will be crucial for the rational design of next-generation nanomaterials for targeted light-mediated cancer therapies. However, as for any novel cancer therapy, before its wide application at the clinical level, it is desired to have a complete understanding of the efficiency, mechanism and toxicity of nanomaterial-based PTT. In this project this will be achieved by developing new nanomaterials, to both induce and probe light-induced hyperthermia. A full understanding of the mechanism behind nanomaterial-mediated PTT requires monitoring the intracellular temperature and cell death pathways during light irradiation. Only a systematic investigation will allow proper adjustment of treatment parameters to achieve the best therapeutic efficiency in solid tumors.

Publication Details

Journal
Lirias (KU Leuven)
Published
2025-10-20
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Het verbeteren van de klinische implementatie van nanogebaseerde kankertherapieën

Lirias (KU Leuven)
Nanoplatforms for cancer theranostics
article

Het verbeteren van de klinische implementatie van nanogebaseerde kankertherapieën

article en

Abstract

Despite significant advances in cancer therapy over the past decades, cancer remains the number one cause of death worldwide. In the last years there has been increasing interest in the development of new treatment modalities with reduced side effects for difficult-to-cure cancers. A prominent example is Photothermal Therapy (PTT), designed to selectively kill cancerous tissue in the body through localized, light-induced thermal stress. The development of nanomaterials marks a significant step forward in photothermal therapy of cancers. Nanomaterials smaller than 200 nm accumulate in the tumour tissue and exhibit strong absorption in the near-infrared range, making them effective photothermal transducers with cancer targeting capabilities. Nanomaterial-mediated PTT has reached clinical trials but knowledge concerning the efficiency, mechanism and toxicity of this therapy remains limited. This project aims to unravel the mechanisms involved in nanomaterial-mediated PTT, using microscopy to monitor intracellular temperature and cell death pathways simultaneously. To mimic the physiological features present in solid tumors most accurately, multicellular tumor spheroids will be used. The fabrication and characterisation of novel nanomaterials will also be a major part of this project, targeting nanosensors for mapping intracellular temperature, and gold-based stimuli-responsive nanocrystals with enhanced solid tumor penetration and efficient photothermal transduction for long-wavelength light. The information obtained thereby will be crucial for the rational design of next-generation nanomaterials for targeted light-mediated cancer therapies. However, as for any novel cancer therapy, before its wide application at the clinical level, it is desired to have a complete understanding of the efficiency, mechanism and toxicity of nanomaterial-based PTT. In this project this will be achieved by developing new nanomaterials, to both induce and probe light-induced hyperthermia. A full understanding of the mechanism behind nanomaterial-mediated PTT requires monitoring the intracellular temperature and cell death pathways during light irradiation. Only a systematic investigation will allow proper adjustment of treatment parameters to achieve the best therapeutic efficiency in solid tumors.

Lirias (KU Leuven)
Good health and well-being
Openalex Percentile: Top 45%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.